FY2023 EPS Estimates for Antibe Therapeutics Inc. (OTCMKTS:ATBPF) Boosted by Zacks Small Cap
FY2023 EPS Estimates for Antibe Therapeutics Inc. (OTCMKTS:ATBPF) Boosted by Zacks Small Cap
Antibe Therapeutics Inc. (OTCMKTS:ATBPF – Get Rating) – Research analysts at Zacks Small Cap upped their FY2023 EPS estimates for shares of Antibe Therapeutics in a report issued on Wednesday, September 7th. Zacks Small Cap analyst D. Bautz now forecasts that the company will post earnings of ($0.35) per share for the year, up from their previous estimate of ($0.36). The consensus estimate for Antibe Therapeutics' current full-year earnings is ($0.31) per share.
安提贝治疗公司(OTCMKTS:ATBPF-GET Rating)--在9月7日星期三发布的一份报告中,Zack Small Cap的研究分析师上调了他们对安提贝治疗公司股票的2023财年每股收益预期。Zack Small Cap分析师D.Bautz现在预测,该公司今年的每股收益将为0.35美元,高于此前预测的0.36美元。对安提贝治疗公司目前全年收益的普遍估计为每股0.31美元。
Separately, Brookline Capital Management reaffirmed a "buy" rating on shares of Antibe Therapeutics in a research report on Thursday, June 30th.
另外,Brookline资本管理公司在6月30日星期四的一份研究报告中重申了对安替比治疗公司股票的“买入”评级。
Antibe Therapeutics Price Performance
安替比治疗药物性价比
Antibe Therapeutics Company Profile
安提贝治疗公司简介
(Get Rating)
(获取评级)
Antibe Therapeutics Inc, a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs.
安提贝治疗公司是一家生物技术公司,致力于在加拿大、欧洲、美国和国际上开发疼痛、炎症和再生医学领域的新型疗法和医疗设备。该公司的药物旨在防止非类固醇抗炎药造成的胃肠道损伤和出血。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Antibe Therapeutics (ATBPF)
- Can Electronic Arts Buck the Downturn in Videogaming?
- Dollar General is the Big Fish in Little Ponds Across the U.S.
- Here's Why the CPI Report will Dictate the Market Bottom
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- 免费获取StockNews.com关于抗菌药物治疗的研究报告(ATBPF)
- 电子艺界能扭转电子游戏市场的低迷吗?
- 美元将军是美国小池塘里的大鱼。
- 以下是CPI报告将决定市场底部的原因
- MarketBeat:回顾一周9/5-9/9
- 为网络安全股创纪录的季度做准备
Receive News & Ratings for Antibe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antibe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接受《安提贝治疗日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对安替比治疗公司和相关公司的最新新闻和分析师评级的每日简要摘要。